NMAVX | VMVAX | NMAVX / VMVAX | |
Total Expense Ratio | 1.19 | 0.07 | 1,700% |
Annual Report Gross Expense Ratio | 1.24 | 0.07 | 1,771% |
Fund Existence | 12 years | 14 years | - |
Gain YTD | 1.824 | 4.815 | 38% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 514M | 30.6B | 2% |
Annual Yield % from dividends | 2.39 | 2.26 | 106% |
Returns for 1 year | -2.75 | 7.48 | -37% |
Returns for 3 years | -0.70 | 22.48 | -3% |
Returns for 5 years | 3.41 | 68.45 | 5% |
Returns for 10 years | 31.22 | 89.00 | 35% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SDCI | 22.34 | 0.20 | +0.88% |
USCF SummerHaven Dyn CmdtyStgy NoK-1 ETF | |||
IYW | 181.29 | 1.31 | +0.73% |
iShares US Technology ETF | |||
RMNY | 23.72 | 0.09 | +0.40% |
Rockefeller New York Municipal Bond ETF | |||
HFRO | 5.20 | -0.03 | -0.57% |
Highland Opportunities and Income Fund | |||
GNOM | 8.95 | -0.06 | -0.72% |
Global X Genomics & Biotechnology ETF |